Close Menu

NIAID

The program will fund partnerships to develop medical diagnostics through R01 and SBIR grants.

The funds will go to study technologies for use in diagnosing, preventing, and treating tuberculosis, malaria, and other neglected diseases.

The $7.3 million in grants will support development of rapid lab and hospital tests.

Recovery Act funds will grant $20 million to worthy RCE projects, a five-year plan may total $455 million, and a new center is planned.

The three centers are at the Broad Institute and the J. Craig Venter Institute, which each won a $43 million contract, and the University of Maryland School of Medicine's Institute for Genome Sciences, which received $20 million.

Short Reads: May 1, 2009

Premium

News in brief

The first in a series of programs will support studies of HIV-1 persistence, including host and pathogen genetics.

Nearly $14 million next year will support centers to study malaria and develop gene-based diagnostics.

Short Reads: Apr 7, 2009

Premium

Genome Analysis Centre, University of Barcelona, NIAID, Massachusetts Institute of Technology, J. Craig Venter Institute, University of Maryland, SeqWright, Hologic, BioReference Laboratories, GeneDx, University of Michigan, Genomatix Software, NHGRI

JCVI, MIT, and the University of Maryland, Baltimore, will use the funds to conduct genome sequencing projects.

Pages

The US National Institutes of Health's All of Us project awarded $4.6 million to the company Color to develop a genetic counseling resource for the program.

The Times of India reports on a pilot study that used genomic testing to determine whether patients had drug-resistant tuberculosis.

New guidelines say that more women may benefit from genetic testing for hereditary breast or ovarian cancer, according to the Los Angeles Times.

In Cell this week: small proteins identified among human microbiome, role for tumor microbes in pancreatic cancer survival, and more.